In AML, specific histone methylome patterns owing to the deregulation of histone methyltransferases and demethylases bring with them a phenotype of disease, this could prove to be key in assessing patient's outcome and treatment regime (69, 134). Here, MBD2 is linked to acute myeloid leukemia.